Events
Advertisement
Advertisement
Trending on Rheumatology Live
1
Upadacitinib Tied to Durable RA Response, With Louis Bessette, MD, MSc
2
Secukinumab Receives FDA Approval for Polymyalgia Rheumatica
3
Nerandomilast Benefit in Autoimmune ILD Consistent by Time Since Diagnosis
4
Ustekinumab Plus Prednisone Improves Sustained Remission in Relapsing GCA
5
